Login / Signup

Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.

Marina Treskova-SchwarzbachFrancisco Pozo-MartinStefan ScholzViktoria SchönfeldOle WichmannThomas Harder
Published in: PharmacoEconomics (2021)
RSV vaccines with anticipated characteristics may reduce a sizeable proportion of the RSV burden. The results are subject to uncertainty because of the limited epidemiological and clinical data. Data on RSV incidence and hospitalisation risk for granular age strata should be prioritised to facilitate the evaluation of RSV interventions and decision making.
Keyphrases
  • respiratory syncytial virus
  • decision making
  • electronic health record
  • big data
  • respiratory tract
  • risk factors
  • machine learning
  • artificial intelligence